Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.32 |
| ▸ | CA1 | P00915 | 4/20 | 0.32 |
| ▸ | CA9 | Q16790 | 4/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | PREP | P48147 | 1/20 | 0.30 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2022429 | 0.82 | CA12 (0.33) | CA12CA1CA9PREP | |
| SCHEMBL15475652 | 0.82 | CA1 (0.38) | CA12CA1CA9SNCAPREP | |
| SCHEMBL5899744 | 0.81 | CA1 (0.38) | CA12CA1CA9SNCACSF1R | |
| SCHEMBL325339 | 0.81 | CA12 (0.33) | CA12CA1CA9 | |
| SCHEMBL9986782 | 0.78 | FFAR1 (0.37) | CA12CA1CA9SNCA | |
| SCHEMBL21835765 | 0.76 | CA12 (0.30) | CA12CA1CA9 | |
| SCHEMBL23123508 | 0.75 | EGFR (0.38) | — | |
| SCHEMBL18736534 | 0.73 | FFAR1 (0.37) | CA12CA1CA9SNCA | |
| SCHEMBL26334789 | 0.73 | FFAR1 (0.34) | CA12CA1CA9SNCAPREP | |
| SCHEMBL13139651 | 0.73 | MAPT (0.45) | CSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200140413-A1 | WATER-SOLUBLE TRIMETHOXYPHENYLPYRIDINE-TYPE COMPLEXING AGENTS, AND CORRESPONDING LANTHANIDE COMPLEXES | CISBIO BIOASSAYS (FR) | 2020-05-07 | — | — | US | disclosed |
| US-10597409-B2 | Water-soluble triazapyridinophane-based complexing agents and corresponding fluorescent lanthanide complexes | CISBIO BIOASSAYS (FR) | 2020-03-24 | — | — | US | disclosed |
| EP-3386974-B1 | WATER-SOLUBLE TRIAZAPYRIDINOPHANE-BASED COMPLEXING AGENTS AND CORRESPONDING FLUORESCENT LANTHANIDE COMPLEXES | CISBIO BIOASSAYS (FR) | 2020-02-05 | — | — | EP | disclosed |
| US-20100267775-A1 | OXADIAZOLIDINEDIONE COMPOUND | ASTELLAS PHARMA INC. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2216330-A1 | OXADIAZOLIDINEDIONE COMPOUND | Astellas Pharma Inc. (JP) | 2010-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140413-A1 | WATER-SOLUBLE TRIMETHOXYPHENYLPYRIDINE-TYPE COMPLEXING AGENTS, AND CORRESPONDING LANTHANIDE COMPLEXES | RCC1, LASP1, POT1 | CA12 841/4885CA1 315/4885CA9 379/4885 |
| US-10597409-B2 | Water-soluble triazapyridinophane-based complexing agents and corresponding fluorescent lanthanide complexes | GSTA1, CLIC1, SLC40A1 | CA12 1289/4885CA1 856/4885CA9 1467/4885 |
| US-20100267775-A1 | OXADIAZOLIDINEDIONE COMPOUND | GPR119, GLP1R, GPR4 | CA12 4685/4885CA1 4452/4885CA9 4122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.